A Multi-Center, Randomized, Double-Blind, Three-Arm, Parallel-Group Trial to Assess the Efficacy and Safety of NTRA-9620 in Infants With Short Bowel Syndrome (SBS) Following Surgical Resection

Trial Profile

A Multi-Center, Randomized, Double-Blind, Three-Arm, Parallel-Group Trial to Assess the Efficacy and Safety of NTRA-9620 in Infants With Short Bowel Syndrome (SBS) Following Surgical Resection

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs NTRA 9620 (Primary)
  • Indications Short bowel syndrome
  • Focus Therapeutic Use
  • Acronyms GIFT
  • Sponsors Nutrinia
  • Most Recent Events

    • 18 Sep 2017 Status changed from recruiting to active, no longer recruiting.
    • 18 Apr 2017 Status changed from not yet recruiting to recruiting.
    • 09 Aug 2016 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top